Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
Fengfeng Li, Man Jiang, Minghui Ma, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1322-1338
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: Strategies, benefits, and challenges
Zhonglei Wang, Liyan Yang
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1373-1390
Closed Access | Times Cited: 43
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
V. A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi
Biomedicines (2022) Vol. 10, Iss. 2, pp. 274-274
Open Access | Times Cited: 37
Theabrownin as a Potential Prebiotic Compound Regulates Lipid Metabolism via the Gut Microbiota, Microbiota-Derived Metabolites, and Hepatic FoxO/PPAR Signaling Pathways
Yue Xiao, Dongmei Yang, Haoran Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 15, pp. 8506-8520
Closed Access | Times Cited: 8
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
Bin Li, Qi Xiao, Hongmei Zhao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3949-3963
Open Access | Times Cited: 5
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Repurposing nitazoxanide as a novel anti‐atherosclerotic drug based on mitochondrial uncoupling mechanisms
Ma Minghui, Fengfeng Li, Wenfeng Li, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 1, pp. 62-79
Open Access | Times Cited: 20
The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Tao Zhang, Yingli Nie, Jiliang Wang
Life Sciences (2023) Vol. 329, pp. 121943-121943
Closed Access | Times Cited: 11
Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway.
Yifei Le, Jianan Guo, Zhijun Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117239-117239
Closed Access | Times Cited: 11
Lactiplantibacillus plantarum Y44 Complex Fermented Milk Regulates Lipid Metabolism in Mice Fed with High-Fat Diet by Modulating Gut Microbiota
Fei Gao, Guangqing Mu, Yanfeng Tuo
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 46, pp. 25767-25781
Closed Access | Times Cited: 4
Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME “two-hit” in mice
Jiahui Chen, Liping Zhang, Ting Xie, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway
Min Tao, Lili Zhang, Guanghong Zhou, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 7
Closed Access
Exploring the nonlinear association between cardiometabolic index and hypertension in U.S. Adults: an NHANES-based study
Huatao Zhou, Yu Mao, Muyao Ye, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Combining RNA-seq, molecular docking and experimental verification to explore the mechanism of BAM15 as a potential drug for atherosclerosis
Minghui Ma, Jiao Zhong, Yu Tai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis
Xuyang Chen, Yan‐Chao Dong, Yuanyuan Yu, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 23, pp. 3008-3023
Closed Access | Times Cited: 10
The clinical antiprotozoal drug nitazoxanide and its metabolite tizoxanide extend Caenorhabditis elegans lifespan and healthspan
Wenfeng Li, Shuming Chen, Jing Lang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3266-3280
Open Access | Times Cited: 3
The antiprotozoal drug nitazoxanide improves experimental liver fibrosis in mice
Kaixin Liu, Z.R. Wang, Yiwei Ying, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116205-116205
Closed Access | Times Cited: 3
New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis
Hoon An, Yerin Jang, Jung-In Choi, et al.
Biomolecules & Therapeutics (2024)
Closed Access | Times Cited: 3
5-Methylcytosine Methylation-Linked Hippo Pathway Molecular Interactions Regulate Lipid Metabolism
Lili Du, Rui Gao, Zhi Chen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2560-2560
Open Access
A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice
Yixiu Zhao, Na Sun, Xia Song, et al.
Free Radical Biology and Medicine (2023) Vol. 203, pp. 69-85
Closed Access | Times Cited: 9
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
Na Cui, Wensen Zhang, Fazhi Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation
Hu-Tai-Long Zhu, Jing Luo, Yi Peng, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111013-111013
Closed Access | Times Cited: 2
Sorafenib extends the lifespan of C. elegans through mitochondrial uncoupling mechanism
Luyao Zheng, Yan-Xin Da, Xiu Luo, et al.
Free Radical Biology and Medicine (2024) Vol. 214, pp. 101-113
Closed Access | Times Cited: 1
PPARγ/NF-κB axis contributes to cold-induced resolution of experimental colitis and preservation of intestinal barrier
Yuzhu Di, Hui Li, Jia Yang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167326-167326
Closed Access | Times Cited: 1
Ellagic Acid Ameliorates Hepatic Functions Against the Hepatic Alterations Induced by Nitazoxanide (Antiprotozoal Drug) in Male Rats
Bander Albogami
International Journal of Pharmacology (2024) Vol. 20, Iss. 7, pp. 1198-1208
Closed Access | Times Cited: 1
Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress
Nevertyty M. Mahmoud, Shimaa M. Elshazly, Fatma El-shaarawy, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top